Welcome to Global Cancer News

- an online media resource, providing you with the latest news in the areas of colorectal cancer, non-small cell lung cancer, and head and neck cancer. You can access comprehensive press kits with everything you need, including an extensive visual and video library, mode of action animations, filmed interviews with leading specialists, disease and clinical information and congress data, to further your knowledge and understanding of these cancer types.

American Society of Clinical Oncology Gastrointestinal Symposium (ASCO GI): 19 - 21 January 2012, San Francisco

The 2012 Gastrointestinal Cancers Symposium Science and Multidisciplinary Management of GI Malignancies took place January 19 - 21, 2012 in San Francisco.

Senseless Symposium

The world premiere of the Senseless Symposium took place on Monday 26 September at the 2011 European Multidisciplinary Cancer Congress.

The theatrical symposium immersed its audience in the world of a head and neck cancer patient, allowing them to experience all stages of the patient journey. ‘Senseless’ is part of a joint Merck Serono and European Head and Neck Society (EHNS) initiative, which aims to help reduce the senseless number of lives lost through lack of disease awareness.

Click here to watch the Senseless play and panel discussion

The 2011 European Multidisciplinary Cancer Congress
(ECCO-ESMO-ESTRO):

23 - 27 September, Stockholm

The 2011 European Multidisciplinary Cancer Congress encompassed the 16th ECCO, the 36th ESMO and the 30th ESTRO Congresses.

At this year’s congress, Merck Serono and the European Head and Neck Society (EHNS) introduced the world premiere of Senseless: a theatrical performance and panel discussion which aims to help reduce the senseless number of lives lost through lack of head and neck cancer awareness.

We invite you to visit the resources below to learn more about the data presented and the activities that took place at EMCC:

About Face 2 Press Release
The EHNS Website
Official Congress Website
Senseless: A Satellite Symposium with a difference
Head and Neck Cancer Call-to-Action

The 2011 WCLC Annual Meeting

July 3 - 7, 2011

The theme of this year’s WCLC Annual Meeting, ‘Better Care Through Personalized Medical Approaches’, is reflected by Merck Serono Oncology’s continued commitment to creating innovative treatment options for cancer patients. With a focus on non-small cell lung cancer (NSCLC), Merck Serono is upholding the personalized therapies theme, by showcasing pioneering new research for Erbitux^® in this disease area.

We invite you to visit the resources below to learn more about the data that were presented; access study authors for interviews; as well as other resources to help you learn more about the latest innovations in cancer today.

Virtual Media Briefings (VMBs)

Filmed Expert Interviews

Official WCLC^® website

Filmed Virtual Media Briefing

Prof O'Byrne, Prof Kerr and Prof Pirker

Virtual Media Briefings with leading experts

Virtual Media Briefing – Professor Ciardiello:

KRAS testing: The future of mCRC management

New survey data, published at ASCO 2010 and WCGIC 2010, have revealed a significant increase in awareness and usage of KRAS testing in the treatment of metastatic colorectal cancer (mCRC).

These virtual media briefings presented by lead author Professor Fortunato Ciardiello provide an overview of the new data as well as an engaging and insightful snapshot of how KRAS testing and personalized therapies are changing the landscape of mCRC management.

Virtual Media Briefing

Hot Topic - Prof Vermorken:

Head and neck cancer – current perspectives on optimal treatment and patient management

Introduction to head and neck cancer
Head and neck cancer is a broad term that covers a range of tumors that occur in the epithelial cells of tissues or organs in the head and neck region, including the oral cavity, pharynx, larynx and nasal cavities, amongst others.

More than 90% of head and neck cancers begin in the flat ‘squamous’ cells that line the surfaces in the head and neck area and are therefore termed ‘squamous cell carcinomas of the head and neck’ (SCCHN) (UPMC Cancer Centers, accessed 2009). Head and neck cancer is the sixth most ..... read more

Download full article